| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.046 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.052 | 0.8 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |